Treatment of ribavirin/interferon-induced anemia with erythropoietin in patients with hepatitis C

Hepatology. 2002 May;35(5):1281-2. doi: 10.1053/jhep.2002.32529.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Anemia / chemically induced
  • Anemia / drug therapy*
  • Antiviral Agents / adverse effects*
  • Drug Therapy, Combination
  • Erythropoietin / therapeutic use*
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Male
  • Middle Aged
  • Recombinant Proteins
  • Ribavirin / adverse effects*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Erythropoietin
  • Ribavirin